FR0011341205
FR0011341205
NANOBIOTIX
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 29.643.000 | -11.610.000 | 355.3% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 40.461.000 | 56.782.000 | 28.7% | |
| Operating Income | -10.818.000 | -68.392.000 | 84.2% |
| Pretax Income | -23.958.000 | -68.032.000 | 64.8% |
| Net Income Common Stockholders | -23.961.000 | -68.132.000 | 64.8% |
| -- | -- | -- | |
| -- | -- | -- |